• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Crohn's Disease Pipeline Highlights - 2014 Update Product Image

Crohn's Disease Pipeline Highlights - 2014 Update

  • ID: 2855560
  • May 2014
  • Fore Pharma

The latest report Crohn's Disease Pipeline Highlights – 2014 Update, provides most up-to-date information on key pipeline molecules in the global Crohn's Disease market. It covers emerging therapies for Crohn's Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Crohn's Disease pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Crohn's Disease pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Crohn's Disease pipeline molecules by the Originator Company.

Short-term Launch Highlights:
Find out which Crohn's Disease pipeline products will be launched in the US and Ex-US till 2017.

SUMMARY:
- Crohn's Disease phase 3 clinical trial pipeline molecules
- Crohn's Disease phase 2 clinical trial pipeline molecules
- Crohn's Disease phase 1 clinical trial pipeline molecules
- Crohn's Disease preclinical research pipeline molecules
- Crohn's Disease discovery stage pipeline molecules
- Crohn's Disease pipeline molecules short-term launch highlights

1. Crohn's Disease Pipeline by Stages
2. Crohn's Disease Pipeline by Drug Class
3. Crohn's Disease Pipeline by Company
4. Crohn's Disease Phase 3 Clinical Trial Insights
5. Crohn's Disease Phase 2 Clinical Trial Insights
6. Crohn's Disease Phase 1 Clinical Trial Insights
7. Crohn's Disease Preclinical Research Insights
8. Crohn's Disease Discovery Stage Insights
9. Appendix
10. Research Methodology
Table 1: Crohn's Disease Phase 3 Clinical Trials, 2014
Table 2: Crohn's Disease Phase 2 Clinical Trials, 2014
Table 3: Crohn's Disease Phase 1 Clinical Trials, 2014
Table 4: Crohn's Disease Preclinical Research, 2014
Table 5: Crohn's Disease Discovery Stage, 2014
Figure 1: Crohn's Disease Pipeline Molecules by Clinical Trials Stage, 2014
Figure 2: Crohn's Disease Pipeline Molecules by Drug Class, 2014
Figure 3: Crohn's Disease Pipeline Molecules by Company, 2014
Figure 4: Crohn's Disease Phase 3 Clinical Trial Highlights, 2014
Figure 5: Crohn's Disease Phase 2 Clinical Trial Highlights, 2014
Figure 6: Crohn's Disease Phase 1 Clinical Trial Highlights, 2014
Figure 7: Crohn's Disease Preclinical Research Highlights, 2014
Figure 8: Crohn's Disease Discovery Stage Highlights, 2014

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos